Are you Dr. Lozanski?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 46 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
410 W 10th Ave
Columbus, OH 43210Phone+1 614-293-5905Fax+1 614-293-4715
Summary
- Dr. Gerard Lozanski, MD is a board certified pathologist in Columbus, Ohio. He is currently licensed to practice medicine in Ohio. He is affiliated with The OSUCCC - James and Ohio State University Wexner Medical Center.
Education & Training
- Summa Health System/NEOMEDResidency, Pathology-Anatomic and Clinical, 1996 - 2001
- University of Medical Science PoznanClass of 1987
Certifications & Licensure
- OH State Medical License 1998 - 2026
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Publications & Presentations
PubMed
- LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclax-resistant chronic lymphocytic leukemia.Janani Ravikrishnan, Daisy Y Diaz-Rohena, Elizabeth Muhowski, Xiaokui Mo, Tzung-Huei Lai
Haematologica. 2024-08-08 - 3 citationsHairy cell leukemia variant and WHO classification correspondence Re: 5edition WHO classification haematolymphoid tumors: lymphoid neoplasms.Michael Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji
Leukemia. 2024-07-01 - 7 citationsFollow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL.Jennifer A Woyach, Gabriela Perez Burbano, Amy S Ruppert, Cecelia Miller, Nyla A Heerema
Blood. 2024-04-18
Press Mentions
- Ohio State to Study Impact of COVID-19 in First Responders with $10 Million GrantSeptember 21st, 2020
- Ohio State to Study COVID-19 in First Responders with $10 Million GrantJuly 9th, 2023
- Ohio State Researchers Cross Disciplines to Establish National STOP-COVID CenterAugust 10th, 2023